GlassScriptPhysician profile
Donna M Gray
NPI 1437482346
$9,737.77
in general payments reported to CMS, 2019-2025
40 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,711 · 2022: $2,737 · 2023: $1,796 · 2024: $1,484 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,288.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,534.54 | 2021-2025 | |
| Amgen INC. | $1,274.48 | 2021-2025 | Repatha, Otezla, Repatha |
| Biohaven Pharmaceuticals, INC. | $974.47 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $699.01 | 2022 | |
| Novo Nordisk INC | $679.09 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $639.06 | 2021-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $417.63 | 2021-2025 | Caplyta |
| Pfizer INC. | $378.24 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $360.09 | 2021-2025 | Airsupra |
| Lilly USA, LLC | $321.05 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $201.84 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $176.24 | 2021-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $158.40 | 2021-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $147.37 | 2025 | Fanapt, Hetlioz |
| Dexcom, INC. | $139.80 | 2022-2025 | Dexcom G6 Transmitter |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.